Jaume Carrió

703 total citations
14 papers, 571 citations indexed

About

Jaume Carrió is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Hepatology. According to data from OpenAlex, Jaume Carrió has authored 14 papers receiving a total of 571 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Public Health, Environmental and Occupational Health, 6 papers in Epidemiology and 3 papers in Hepatology. Recurrent topics in Jaume Carrió's work include Research on Leishmaniasis Studies (9 papers), Trypanosoma species research and implications (3 papers) and Hepatitis C virus research (3 papers). Jaume Carrió is often cited by papers focused on Research on Leishmaniasis Studies (9 papers), Trypanosoma species research and implications (3 papers) and Hepatitis C virus research (3 papers). Jaume Carrió collaborates with scholars based in Spain and United States. Jaume Carrió's co-authors include Montserrat Portús, Cristina Riera, Montserrat Gállego, Roser Fisa, Soledad Castillejo, T. Serra, M. Arboix, Javier González Gallego, Núria Ribas and Josep Enric Valladares and has published in prestigious journals such as Journal of Antimicrobial Chemotherapy, American Journal of Tropical Medicine and Hygiene and Veterinary Parasitology.

In The Last Decade

Jaume Carrió

14 papers receiving 547 citations

Peers

Countries citing papers authored by Jaume Carrió

Since Specialization

Citations

This map shows the geographic impact of Jaume Carrió's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jaume Carrió with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jaume Carrió more than expected).

Fields of papers citing papers by Jaume Carrió

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jaume Carrió. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jaume Carrió. The network helps show where Jaume Carrió may publish in the future.

Co-authorship network of co-authors of Jaume Carrió

This figure shows the co-authorship network connecting the top 25 collaborators of Jaume Carrió. A scholar is included among the top collaborators of Jaume Carrió based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jaume Carrió. Jaume Carrió is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Clinical performance of a new multiplex assay for the detection of HIV‐1, HIV‐2, HCV, HBV, and HEV in blood donations in Catalonia (Spain) 2023 ·Transfusion ·Sílvia Sauleda, Marta Bes, María Pirón, Edgar Ong, (unknown), Jaume Carrió, Jeffrey M. Linnen	2
2	Epidemiology, molecular characterisation and antimicrobial susceptibility ofNeisseria gonorrhoeaeisolates in Madrid, Spain, in 2016 2019 ·Epidemiology and Infection ·(unknown), (unknown), (unknown), (unknown), (unknown), Petunia Clavo, Teresa Puerta, (unknown), (unknown), Jaume Carrió, (unknown), Jorge del Romero, Julio A. Vázquez, Raquel Abad	9
3	Asymptomatic infection by Leishmania infantum in blood donors from the Balearic Islands (Spain) 2008 ·Transfusion ·Cristina Riera, Roser Fisa, Paulo López-Chejade, T. Serra, (unknown), Teresa Jimenéz‐Marco, (unknown), (unknown), (unknown), (unknown), Montserrat Gállego, Jaume Carrió, Alejandro Forteza, Montserrat Portús	86
4	In vitro evaluation of the effectiveness and cytotoxicity of meglumine antimoniate microspheres produced by spray drying against Leishmania infantum 2008 ·Parasitology Research ·(unknown), Josep M. Suñé‐Negre, (unknown), E. Torres-Garcı́a, Montserrat Portús, Josep R. Ticó Grau, Montserrat Miñarro Carmona, Jaume Carrió	26
5	Efficacy of liposomal amphotericin B for secondary prophylaxis of visceral leishmaniasis in HIV-infected patients 2007 ·Journal of Antimicrobial Chemotherapy ·Israel Molina, Vicenç Falcó, Manuel Crespo, Cristina Riera, Esteban Ribera, Adrián Curran, Jaume Carrió, Montserrat Díaz, S Villar del Saz, Roser Fisa, Paulo López-Chejade, I Ocaña, Albert Pahissa	46
6	VALUE OF CULTURE AND NESTED POLYMERASE CHAIN REACTION OF BLOOD IN THE PREDICTION OF RELAPSES IN PATIENTS CO-INFECTED WITH LEISHMANIA AND HUMAN IMMUNODEFICIENCY VIRUS 2005 ·American Journal of Tropical Medicine and Hygiene ·Cristina Riera, Roser Fisa, Esteban Ribera, Jaume Carrió, Vicenç Falcó, Montserrat Gállego, (unknown), Israel Molina, Montserrat Portús	27
7	In vitro susceptibility to pentavalent antimony in Leishmania infantum strains is not modified during in vitro or in vivo passages but is modified after host treatment with meglumine antimoniate 2002 ·BMC Pharmacology ·Jaume Carrió, Montserrat Portús	38
8	In vitro activity of pentavalent antimony derivatives on promastigotes and intracellular amastigotes of Leishmania infantum strains from humans and dogs in Spain 2001 ·Acta Tropica ·Jaume Carrió, Cristina Riera, Montserrat Gállego, Montserrat Portús	17
9	Leishmania infantum: Stage-Specific Activity of Pentavalent Antimony Related with the Assay Conditions 2000 ·Experimental Parasitology ·Jaume Carrió, Marı́a Colmenares, Cristina Riera, Montserrat Gállego, M. Arboix, Montserrat Portús	41
10	Serological and parasitological follow-up in dogs experimentally infected with Leishmania infantum and treated with meglumine antimoniate 1999 ·Veterinary Parasitology ·Cristina Riera, Josep Enric Valladares, Montserrat Gállego, (unknown), Soledad Castillejo, Roser Fisa, Núria Ribas, Jaume Carrió, Jordi Alberola, M. Arboix	126
11	Epidemiology of canine leishmaniosis in Catalonia (Spain) 1999 ·Veterinary Parasitology ·Roser Fisa, Montserrat Gállego, Soledad Castillejo, (unknown), T. Serra, Cristina Riera, Jaume Carrió, Javier González Gallego, Montserrat Portús	131
12	Markers of Hepatitis C Infection among Hemodialysis Patients with Acute and Chronic Infection: Implications for Infection Control Strategies in Hemodialysis Units 1995 ·The International Journal of Artificial Organs ·(unknown), Guadalupe Ercilla, (unknown), Miguel Bruguera, Jaume Carrió, (unknown)	5
13	Late seroconversion of C virus markers in hemodialysis patients. 1993 ·PubMed ·(unknown), (unknown), Jaume Carrió, (unknown), (unknown)	11
14	[Mycobacterium fortuitum in patients with chronic renal insufficiency: apropos of 2 cases]. 1990 ·PubMed ·(unknown), (unknown), (unknown), Xosé M. Lens, Jaume Carrió, (unknown)	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact